sponsored
PatientsVille.com Logo

PatientsVille

Cymbalta and Dilaudid

Compare Side Effects

% of total side effects reported by users. DISCLAIMER: ALL DATA PROVIDED AS-IS. Data Source: openfda.gov.
Side EffectCymbaltaDilaudid
DEATH0.4% 15.9%
TOXICITY TO VARIOUS AGENTS0% 12.2%
OVERDOSE0% 7.8%
NAUSEA4.3% 2.6%
DIZZINESS3.6% 1%
FATIGUE3.3% 1.7%
HEADACHE3.2% 1.2%
DRUG WITHDRAWAL SYNDROME3% 0.8%
PAIN2.4% 2.9%
INSOMNIA2.8% 0.7%
DRUG INEFFECTIVE2.7% 1.8%
ANXIETY2.5% 0.9%
PARAESTHESIA2.4% 0.4%
DRUG ABUSE0% 2.1%
DIARRHOEA2% 1.4%
DEPRESSION2% 0.6%
VOMITING1.9% 1.8%
SUICIDAL IDEATION1.9% 0%
HYPERHIDROSIS1.8% 0.5%
FEELING ABNORMAL1.8% 0.5%
IRRITABILITY1.6% 0%
FALL1.5% 1%
OFF LABEL USE1.5% 0.8%
CONFUSIONAL STATE1.5% 0.6%
DRUG DEPENDENCE0% 1.5%
AGITATION1.5% 0%
MALAISE1.4% 0.9%
DRUG HYPERSENSITIVITY0.6% 1.4%
TREMOR1.4% 0.4%
DYSPNOEA1.2% 1.3%
ARTHRALGIA1.3% 0.9%
VERTIGO1.3% 0%
ASTHENIA1.2% 1%
SOMNOLENCE1.2% 0.7%
ABDOMINAL PAIN0.6% 1.1%
WEIGHT INCREASED1.1% 0.4%
DRUG WITHDRAWAL SYNDROME NEONATAL0% 1.1%
BACK PAIN1% 1%
PAIN IN EXTREMITY1% 0.8%
PNEUMONIA0.6% 1%
AFFECT LABILITY1% 0%
WEIGHT DECREASED0.9% 0.8%
PYREXIA0.6% 0.9%
ACCIDENTAL OVERDOSE0% 0.9%
DYSPHORIA0.9% 0%
CONSTIPATION0.8% 0.8%
GAIT DISTURBANCE0.8% 0.6%
MEMORY IMPAIRMENT0.8% 0.3%
LETHARGY0.8% 0.3%
NIGHTMARE0.8% 0%
DECREASED APPETITE0.7% 0.6%
RASH0.7% 0.6%
HYPOAESTHESIA0.7% 0.6%
HYPERTENSION0.7% 0.5%
MUSCLE SPASMS0.7% 0.5%
PRURITUS0.7% 0.5%
DEHYDRATION0.4% 0.7%
DRUG DOSE OMISSION0.7% 0.3%
BLOOD PRESSURE INCREASED0.7% 0.3%
SLEEP DISORDER0.7% 0%
CRYING0.7% 0%
SENSORY DISTURBANCE0.7% 0%
TINNITUS0.7% 0%
CHEST PAIN0.6% 0.6%
INTENTIONAL PRODUCT MISUSE0.6% 0.5%
CONDITION AGGRAVATED0.6% 0.5%
ABDOMINAL PAIN UPPER0.6% 0.4%
LOSS OF CONSCIOUSNESS0.6% 0.4%
HYPOTENSION0.4% 0.6%
MIGRAINE0.6% 0.3%
VISION BLURRED0.6% 0.3%
ANAEMIA0% 0.6%
MOOD SWINGS0.6% 0%
PULMONARY EMBOLISM0% 0.6%
DRY MOUTH0.6% 0%
SUICIDE ATTEMPT0.6% 0%
DRUG INTERACTION0.6% 0%
OEDEMA PERIPHERAL0.5% 0.5%
URINARY TRACT INFECTION0.5% 0.5%
COUGH0.5% 0.4%
MYALGIA0.5% 0.3%
INJURY0% 0.5%
SEPSIS0% 0.5%
INFECTION0% 0.5%
DEPRESSED MOOD0.5% 0%
DISTURBANCE IN ATTENTION0.5% 0%
WITHDRAWAL SYNDROME0.5% 0%
PALPITATIONS0.5% 0%
BALANCE DISORDER0.5% 0%
ALOPECIA0.5% 0%
CHILLS0.4% 0.4%
CONTUSION0.4% 0.3%
HALLUCINATION0.4% 0.3%
ABDOMINAL DISCOMFORT0.4% 0.3%
NEUROPATHY PERIPHERAL0.4% 0.3%
MUSCULAR WEAKNESS0.4% 0.3%
HEART RATE INCREASED0.4% 0.3%
NERVOUSNESS0.4% 0%
FIBROMYALGIA0.4% 0%
MALIGNANT NEOPLASM PROGRESSION0% 0.4%
HYPERSENSITIVITY0.4% 0%
HAEMOGLOBIN DECREASED0% 0.4%
DISEASE PROGRESSION0% 0.4%
PERIPHERAL SWELLING0% 0.4%
DEEP VEIN THROMBOSIS0% 0.4%
ALANINE AMINOTRANSFERASE INCREASED0.4% 0%
BLOOD GLUCOSE INCREASED0.4% 0%
RHEUMATOID ARTHRITIS0% 0.4%
HEPATIC ENZYME INCREASED0.4% 0%
SEIZURE0.4% 0%
SINUSITIS0.4% 0%
SYNCOPE0.4% 0%
PANIC ATTACK0.4% 0%
ANGER0.4% 0%
INJECTION SITE PAIN0.4% 0%
AMNESIA0.4% 0%
INFLUENZA LIKE ILLNESS0.4% 0%
ABDOMINAL DISTENSION0% 0.3%
TACHYCARDIA0% 0.3%
HERPES ZOSTER0% 0.3%
UNRESPONSIVE TO STIMULI0% 0.3%
CELLULITIS0% 0.3%
SUBSTANCE ABUSE0% 0.3%
ERYTHEMA0% 0.3%
THROMBOCYTOPENIA0% 0.3%
EMOTIONAL DISTRESS0% 0.3%
DYSPHAGIA0% 0.3%
ARTHRITIS0% 0.3%
MENTAL STATUS CHANGES0% 0.3%
RESPIRATORY FAILURE0% 0.3%
PLEURAL EFFUSION0% 0.3%
RENAL FAILURE0% 0.3%
GENERAL PHYSICAL HEALTH DETERIORATION0% 0.3%
JOINT SWELLING0% 0.3%
SWELLING0% 0.3%

New treatments are found every day. View current Cymbalta research studies and Dilaudid clinical trials

1